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Glycosphingolipids are involved in the first steps of virus-cell interaction, where they mediate specific
recognition of the host cell membrane. We have employed total-internal-reflection fluorescence micros-
copy to explore the interaction kinetics between individual unlabeled noroviruslike particles, which are
attached to a glycosphingolipid-containing lipid bilayer, and fluorescent vesicles containing different
types and concentrations of glycosphingolipids. Under association equilibrium, the vesicle-binding rate is
found to be kinetically limited, yielding information on the corresponding activation energy. The
dissociation kinetics are logarithmic over a wide range of time. The latter is explained by the vesicle-
size-related distribution of the dissociation activation energy. The biological, pharmaceutical, and
diagnostic relevance of the study is briefly discussed.
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Viruses consist of DNA or RNA genomes protected by a
protein capsid or a lipidic membrane envelope. Their rep-
lication cycles include virion attachment to a host cell,
penetration, uncoating and release of genome, genome
replication, viral protein synthesis, capsid assembly, and
escape from the host [1]. An in-depth understanding of
these processes plays a key role for development of anti-
viral therapies, vaccines, and high-performance diagnos-
tics. Huge efforts are therefore undertaken to develop
assays capable of elucidating virus-cell interactions with
high sensitivity. Recently, techniques have emerged [2,3]
that enable real-time optical visualization of single virions
in live cells. This represents an important progress over
conventional transmission electron microscopy, as these
techniques make it possible to quantify the dynamics of
the infectious entry pathway. Commonly used cell-based
techniques are complemented with in vitro bioanalytical
assays employing model surface-supported cell mem-
branes of chosen composition [4–6]. Such studies, focused
on, e.g., ensemble-averaged recording of binding to model-
supported lipid bilayers [5] and virus imaging [6], provide
basic knowledge about the contribution of individual com-
ponents to the processes under consideration.
Motivated by the challenge of quantifying binding at
early stages of infection, we have designed a setup to
investigate binding kinetics between surface-immobilized
virions and model membranes in the form of freely diffus-
ing vesicles [Fig. 1(a)]. Individual fluorescent vesicles
were tracked over time with total-internal-reflection fluo-
rescence microscopy (TIRFM), enabling the vesicles in
close proximity to the virus particles to be selectively
illuminated, while the background fluorescence from
vesicles in solution is efficiently suppressed. This means
that, with the virus particles sufficiently separated on the
surface, the lipid vesicles can be used to identify individual
virus particles as shown in Fig. 1(b), while at the same time
single association and dissociation events can be recorded
under equilibrium conditions [7].
Although the concept is generic, we focus in this work
on the norovirus genogroup II.4 Dijon strain [8–10] and its
interaction with membranes containing the glycosphingo-
lipids (GSLs) H type 1 and Lewis b [5(b)]. Norovirus is
a nonenveloped RNA virus, 38 nm in diameter, with a
symmetric icosahedral capsid assembled from 180 copies
of the capsid protein arranged into 30 hexagonal facets [11]
(Fig. S4 in Ref. [12]). Since there are no in vitro culture
systems for human noroviruses, we employ self-assembled
capsid proteins recombinantly expressed in insect cells,
because such viruslike particles (VLPs) exhibit a morphol-
ogy and binding characteristics similar to those of real
viruses [13]. These VLPs recognize a variety of cell sur-
face glycoconjugates [9], which are often involved in the
first step of virion-cell interaction [14].
The VLPs were first bound to a supported 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine lipid bilayer contain-
ing 5% H type 1 as ligands [Fig. 1(a)]. The zwitterionic
background lipids make the surface highly resistant to
nonspecific protein and vesicle binding [15], while the
included GSLs promote a firm and specific VLP attach-
ment. Subsequent addition of GSL-containing phospholi-
pid vesicles, each including 1000 fluorescently labeled
lipids, enables binding and dissociation kinetics to be
measured by using TIRFM over a broad time regime (the
details of assay preparation and imaging are in Ref. [12]).
The influence of vesicle size (61 24 or 163 87 nm)
and GSL content (2 or 5%) on association and dissociation
kinetics was explored by using H type 1. In addition,
H type 1 was replaced by Lewis b (which differs from
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H type 1 by the presence of one additional sugar unit),
and the influence on binding kinetics was investigated.
Therefore, the reported results correspond to vesicles of
four types with size and GSL fractions: (I) 163 nm and 5%
H type 1, (II) 163 nm and 2% H type 1, (III) 61 nm and 5%
H type 1, and (IV) 163 nm and 5% Lewis b.
A key advantage of the concept employed here is that it
allows studies of the kinetics not only in transient condi-
tions but also in steady-state conditions, thus avoiding
global diffusion limitations. Once binding equilibrium
was reached, the association kinetics were investigated
by recording the number of newly arrived vesicles, nþ,
during the shortest times between frames (0.5 s). (To
ensure that the system had time to relax towards equilib-
rium, the vesicles were added at least 30 min before the
measurements were performed. The extension of this in-
terval to 2 h did not change the results.) The linear incre-
ment of nþ vs time observed for vesicles of different types
(Fig. 2) is consistent with steady-state conditions. The
corresponding association rate can be represented as
dnþ=dt ¼ kaNVLPCves, where ka is the rate constant,
NVLP the VLP surface coverage, and Cves the concentration
of vesicles in solution. We have used Cves ¼ 1:25 and
0:35 pM for the 61 and 163 nm vesicles, respectively.
Based on binding experiments performed by using quartz
crystal microbalance with dissipation monitoring, NVLP
was estimated to be 10 VLP m2. Employing these
values and a linear fit (y ¼ ax) of the kinetics over the
whole data range yields ka ¼ ð4:0 1:3Þ  107, ð1:1
0:4Þ  107, and ð1:3 0:7Þ  107 M1 s1 for vesicles of
types I, II, and III, respectively (the standard deviation was
calculated from 4 measurements).
Although no global diffusion limitations are present, the
elementary association events can be limited by vesicle
diffusion (lateral diffusion of attached VLPs is not ob-
served in our case); i.e., one should have ka  kD ’
2RcDves, where Rc ¼ 19 nm is the VLP capsid radius
and Dves is the vesicle diffusion coefficient [12]. Using the
hydrodynamicDves values 7.1 and 2:65 m
2=s for 163 and
61 nm vesicles, respectively, we obtain kD ’ 2 108 for
vesicles of types I and II and 5:3 108 M1 s1 for
vesicles of type III. In cases II and III, these values are
appreciably larger than the measured ones, suggesting that
the binding is kinetically limited. For vesicles of type I, ka
approaches the diffusion limit, which is attributed to their
relative large size and higher GSL content. Using the
Arrhenius representation, ka ¼ kD expðEa=kBTÞ, and
the values of ka and kD above, we have estimated the
activation energy for association, Ea ¼ 0:078 and
0.10 eV (1.8 and 2:4 kcal=mol), for vesicles of types II
and III, respectively. These low values are physically
reasonable, because the association is expected to start





FIG. 1 (color online). Detection principle: (a) VLPs, immobilized on a supported lipid bilayer containing GSLs, interact with
fluorescently labeled vesicles containing the GSL of interest. TIRF-based illumination is used to track surface-bound vesicles. (b) A
typical TIRF image of surface-bound vesicles together with a kymograph and the intensity profile of a small image area containing a
single vesicle. (c) Amount of newly arrived vesicles as a function of time. (d) Vesicle residence times for different time-lapse series.
The data displayed here are for the 163 nm vesicles of type I.




VLP binding to GSL-containing lipid bilayers is gov-
erned by multiple weak interactions, which combined lead
to high binding avidity. This makes information about
dissociation kinetics challenging to acquire. Here, vesicle
release was quantified by extracting the residence time of
individual GSL-containing vesicles from time-lapse im-
ages [Fig. 1(d)] and displaying the number of vesicles still
attached after a certain binding time (see, e.g., Fig. 3). To
cover a broad range of residence times, time lapses of three
different durations (150 s, 10 min, and 1 h) with different
times between the frames (0.5, 2, and 20 s, respectively)
were acquired. Guided by control experiments performed
in the absence of VLPs or GSLs in the vesicles, a vesicle
was considered as bound if it was present in at least three
consecutive frames, setting thus the shortest residence time
analyzed to 6 [Fig. 3(a)] or 1.5 s [Fig. 3(b)].
To further illustrate the potential of the method, the
GSLs H type 1 and Lewis b were compared. While the
interaction patterns with these species were essentially
identical when a conventional ensemble-averaging tech-
nique was used (Fig S3 in Ref. [12]), Fig. 3(a) shows that
subtle differences in the interaction strength between the
two GSLs can be resolved with single VLP sensitivity.
Interestingly, the release kinetics exhibit a distinct slow-
down with increasing time manifested as a broad distribu-
tion in residence times [Fig. 1(d)]. To illustrate this feature
over a wide time interval, it is helpful to use logarithmic
coordinates. Specifically, we show ln½WðtÞ=nð0Þ vs lnðtÞ
(Fig. 4), where WðtÞ  dnðtÞ=dt is the dissociation rate
and nðtÞ the number of vesicles bound (to minimize the
noise, the data from the original time intervals were binned
into larger time intervals; see Fig S2 in Ref. [12]). In all
cases, the data exhibit a linear behavior with a character-
istic slope fairly close to 1 over a very wide range of
residence time (from 1 to about 103 s).
The dissociation rate constant for a vesicle of a given
size depends on the corresponding activation energy E,
determined primarily by the number of the GSL-capsid-
protein bonds, and on the fraction of GSLs. To interpret the
logarithmic kinetics, it is sufficient to focus on the activa-
tion energy, because energetics is the key factor in rate
processes. Let us consider that, due to the vesicle-size
distribution, E is distributed in the range from Emin to
Emax. Assuming the preexponential factor for dissociation
to be constant, we can represent the dissociation rate
constant as kðEÞ ¼ kmax exp½ðE EminÞ=kBT, where
kmax is the maximum value. The number of bound species
is given by nðtÞ ¼ nð0ÞREmaxEmin fðEÞ exp½kðEÞtdE, where
fðEÞ is the distribution of E. Combining these expressions
with the simplest rectangular distribution (f ¼ 1=E with
E  Emax  Emin) and considering the kinetics to be
studied in the time interval 1=kmax  t 1=kmin, we
FIG. 3 (color online). Number of vesicles (arbitrary units) that
are still bound as a function of time for (a) (from top to bottom)
vesicles of types I (163 nm, 5% H type 1, red circles) and IV
(163 nm, 5% Lewis b, light blue diamonds) and (b) (from top to
bottom) vesicles of types I (163 nm, 5% H type 1, red circles), III
(61 nm, 5% H type 1, blue triangles), and II (163 nm, 2% H type
1, black squares). The time lapses are (a) 0.5 and (b) 2 s.
FIG. 2 (color online). Number of newly arrived vesicles as a
function of dose Cvest for (from top to bottom) vesicles of types I
(163 nm, 5% H type 1, red curve), III (61 nm, 5% H type 1, blue
curve), and II (163 nm, 2% H type 1, black curve). Control
experiments were performed with fluorescent vesicles which did
not contain GSL (163 nm, 0%, green curve) or in the absence of
VLPs (163 nm, 10% H type 1, light blue curve). Both controls
exhibit a hundredfold reduction in the association amount
(the corresponding lines nearly coincide) compared to vesicles
of type I. The measurements were executed with the time lapses
of 0.5 s.




obtain WðtÞ ¼ dnðtÞ=dt ’ nð0ÞkBT=ðtEÞ (for further
details, see Ref. [12]). This expression, rewritten as
ln½WðtÞ=nð0Þ ¼ lnðkBT=EÞ  lnðtÞ, indicates, in good
agreement with the experiment, that ln½WðtÞ=nð0Þ linearly
depends on lnðtÞ and the corresponding slope is 1.
In natural sciences, the observations of logarithmic ki-
netics (as in Fig. 4) over a broad time range are not
frequent. Such kinetics are usually associated with a broad
distribution of one of the parameters controlling a rate
process, in our case the activation energy of dissociation.
As shown in Fig. 3(b), a decrease in vesicle size (from 163
to 61 nm) or a decrease in ligand concentration (from 5% to
2%) results in an increase in the fraction of vesicles dis-
playing shorter residence times. The binding energy be-
tween a GSL and capsid protein is weak ( 0:1 eV), and
firm binding occurs upon formation of several such bonds.
In analogy with the initial stage of the virus entry by
endocytosis [1], this process is expected to be facilitated
by vesicle deformation allowing for an increase in the
number of bonds. Deformation is more feasible for larger
vesicles. For these reasons, the two likely factors behind
the logarithmic kinetics of dissociation are (i) different
GSL fractions in different vesicles and (ii) distribution of
vesicle sizes. The role of the former factor seems to be
minor, because the average number of GSLs per vesicle is
large ( 12 000,5000, and700 for vesicles of types I,
II, and III, respectively), and the fluctuations of this num-
ber are negligible. The latter factor appears to be more
important, because the size distributions of extruded
vesicles is broad (the full width at half maximum is close
to the average; see Fig S1 in Ref. [12]).
In the case of logarithmic kinetics, the rate of a process
at a given time t is determined by the participants with the
rate constant k ’ 1=t. In our context (Fig. 4), this means
that we observe dissociation with rate constants in the
range from about 103 to 1 s1. Assuming for estimates
that the preexponential factor for this process is normal
(1013 s1), and, taking into account that the experiments
were performed at room temperature, we obtain that the
dissociation activation energies corresponding to our ex-
periments are in the range from 0.78 to 0.95 eV. Dividing
these values by the energy of a single GSL-protein bond,
we can estimate the number of GSLs participating in the
association. As already noted, the single bond is weak.
Using, e.g., 0.13 eV (3 kcal=mol), we obtain that the
number of GSLs is between 6 and 8. These values are in
good agreement with estimates based on geometrical and
structural considerations predicting that the number of
bonds is between 6 and 12 [12].
In summary, the main outcome of our work is as follows.
(i) The single viral particle sensitivity, combined with
the possibility to extract kinetic rate constants under sta-
tionary conditions, makes the TIRFM-based platform dem-
onstrated in this work especially attractive to investigate
simultaneously weak (few ligands) and strong (multiple
ligands) interactions. It allows the study of heterogeneous
binding systems over a broad range of residence times and
without ensemble averaging. The simplicity of the assay,
which does not require labeling of the viral particles,
combined with low material consumption, makes it attrac-
tive in pharmaceutics, where methods allowing for
screening of new compounds inhibiting virus binding
and spreading are highly desirable. The single viral
particle sensitivity makes it also competitive with conven-
tional quantitative polymerase-chain-reaction-based diag-
nostics [8].
(ii) Our experiments with norovirus VLPs and vesicles
containing glycosphingolipids indicate that the association
rate constant of these species is lower than that expected
for the diffusion-limited case. This finding in combination
with the obtained information about the VLP-vesicle bind-
ing energy is useful for understanding the very first steps of
interaction between virions and the host cell membrane,
which was so far mainly focused on identification of the
capsid binding sites responsible for this interaction [11].
(iii) The VLP-vesicle dissociation kinetics are observed
to be logarithmic over a large range of time. This feature
has been explained by multiple contacts between a vesicle
and VLP and vesicle deformation. Such situations may
occur at GSL-enriched cell-membrane regions with posi-
tive curvature [16]. This allows us to speculate that the
logarithmic kinetics of the type observed may take place
in vivo.
(iv) The dissociation kinetics also allow us to discrimi-
nate between two structurally similar GSLs, known from
time-unresolved and semiquantitative assays to bind firmly
to norovirus VLPs [17]. This observation is an additional
argument in favor of potential applications of the technique
for investigating constantly evolving virus strains.
FIG. 4 (color online). Logarithmic plots of dissociation rate for
(from top to bottom) vesicles of types II (163 nm, 2% H type 1,
black squares), III (61 nm, 5% H type 1, blue triangles), and I
(163 nm, 5% H type 1, red circles) (time is in seconds). The data
from the 0.5, 2, and 20 s time lapses have been merged and fitted
linearly.
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